Skip to content
Riskpilot
← Back to search
Sign in
Get full access
HyperBio Therapeutics ApS
APS
In liquidation
Advertising protection
CVR 41244909
Stærmosevej 12, 7120
Vejle Øst
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2020 · 6 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
HyperBio Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-4M
-8M
-12M
-16M
-6M
2020
-13M
-117%
2021
-9M
+31%
2022
0M
+100%
2023
EBITDA
DKK millions
0M
-4M
-8M
-12M
-16M
-6M
2020
-13M
-117%
2021
-9M
+31%
2022
0M
+100%
2023
Income statement
DKK thousands
Item
2020
2021
2022
2023
Gross profit
-5.571
-12.882
-8.629
-74
Staff expenses
-40
-60
-55
-0
EBITDA
-5.611
-12.942
-8.684
-74
Depreciation & amort.
-0
-0
-0
-0
EBIT
-5.611
-12.942
-8.684
-74
Net financials
-20
-479
-1.322
-1.176
Profit before tax
-5.632
-13.421
-10.006
-1.250
Tax
-1.573
-2.808
-2.349
-277
Net profit
-4.058
-10.613
-7.656
-973
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
Total assets
12.036
22.827
15.672
14.654
Equity
10.982
5.369
-2.287
740
Long-term debt
0
15.355
0
0
Short-term debt
1.054
2.103
17.959
13.914
Total debt
1.054
17.458
17.959
13.914
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-7448400.0%
This company
2020
2023
Equity ratio
5.0%
This company
38.2%
Market median
87% below market
2020
2023
Return on equity
-131.5%
This company
18.4%
Market median
815% below market
2020
2023
Net profit margin (of gross profit)
-97274700.0%
This company
2020
2023
Asset turnover (of gross profit)
-0.01×
This company
2020
2023
Debt / equity
18.81×
This company
0.62×
Market median
2934% above market
2020
2023
Annual reports & filings
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-03-12 – 2020-12-31
View
PDF
More on HyperBio Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
